Aster Capital Management’s United Therapeutics UTHR Stock Holding History

Aster Capital Management’s Portfolio UTHR Stock Details UTHR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$584K	Buy	1,078 +1,069	+11,878%	+$602K	0.12%	236
2026 Q1	$2.77K	Sell	9 -741	-99%	-$369K	﹤0.01%	734
2025 Q4	$365K	Buy	750 +581	+344%	+$271K	0.16%	127
2025 Q3	$70.8K	Sell	169 -397	-70%	-$134K	0.04%	432
2025 Q2	$163K	Sell	566 -1,111	-66%	-$332K	0.04%	424
2025 Q1	$537K	Buy	1,677 +1,590	+1,828%	+$545K	0.1%	274
2024 Q4	$30.7K	Sell	87 -852	-91%	-$313K	0.01%	566
2024 Q3	$336K	Buy	+939	New	+$317K	0.07%	246

Other funds holding UTHR

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Norges Bank Oslo, Norway $1T AUM

Aster Capital Management's UTHR Position: Q2 2026 in Review

Aster Capital Management increased its United Therapeutics (UTHR) stake by 11,878% in Q2 2026, buying an estimated $602K and bringing the position to 1,078 shares worth $584K. The position accounts for 0.12% of the portfolio, ranked #236.

Aster Capital Management first reported a position in UTHR in Q3 2024 and has held it in 8 quarters since. 882 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

Aster Capital Management held 1,078 shares of United Therapeutics worth $584K as of Q2 2026.
Aster Capital Management bought 1,069 United Therapeutics shares in Q2 2026, an estimated $602K.
United Therapeutics made up 0.12% of Aster Capital Management's portfolio in Q2 2026, its #236 holding.
Aster Capital Management first reported a position in United Therapeutics in Q3 2024 and has held it in 8 quarters since.
882 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Aster Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.